
By acquiring Monkeys not Donkeys, QbD will strengthen its "from idea to patient" offering.


By acquiring Monkeys not Donkeys, QbD will strengthen its "from idea to patient" offering.

The agreement will expand Univar Solutions' diverse excipient portfolio, helping customers with drug delivery in Brazil and Mexico.

In his new role, Avallone will be responsible for growing the Evoke data team, expanding their data offerings around audience insights and analytics, and providing high-value consultancy to clients.

Award-winning Healthcare IT PR agency to collaborate with leader in modernizing payer workflows to amplify client successes and industry best practices.

What’s next and lasting in engagement for medical affairs and commercial teams isn’t complicated, but a big shift is here to stay, according to analysis of an industry survey.

The metaverse has arrived - what exactly is it and how is it on the cusp of offering tremendous opportunity for healthcare brands?

Rebecca will work across the VUE Health companies, including its cross-cultural arm Latitude Health.

The appointment reinforces the global healthcare communications network commitment to its ‘Power of One’ model.

The acquisition creates an end-to-end pharmaceutical product commercialization and launch excellence capability that optimizes and accelerates patient access to medical advances.

Miller joins as the Chief Business Officer/Chief Operating Officer, bringing decades of corporate strategy and business development experience in the biotech and pharmaceutical industries.

Education and knowledge transfer must be prioritized for industry to see sizable improvement in medical affairs.

Pharma trailblazer will accelerate growth at COTA with a focus on advancing real-world data use in drug development, increasing diversity in clinical trials, and supporting the move to data-driven, value-based cancer care.

The collaboration leverages Insilico's end-to-end AI-driven Pharma.AI platform to discover novel small molecule drug candidates for multiple targets, along with EQRx's innovative business model to accelerate drug development and patient access to novel medicines at affordable prices.

Augustin, a Senior Creative Strategist at Artemis Ward, leads the PhRMA account and provides a strategic lens to the overall work.

OCE+ is the first of several new advancements to IQVIA's leading life science customer engagement platform.

In this newly created role, Peter will drive the overall impact of the agency’s work by infusing breakthrough creativity and insight-informed strategy across the business.

Kinsella will initially be charged with building out the multilingual team and service across Europe, North & South America while forging new relationships with meeting and events owners in those territories.

Matthew Howes, President at Greater Than One, discusses what to expect in the next twelve months in healthcare marketing.

Full-year business review of pharma and biotech sectors reveals strong momentum in advancing novel science and treatments, but likely foretells continued stock instability in near-to-medium terms.

Connected TV advertising now a critical component of media mix.

Q&A with Hettie Stroebel, Founder and CEO of Launch Excellence.

Insights. How can pharma companies solve the insights gap through better insights management?

Q&A with Ross Krentzman, VP of Sales at Intersection, to discuss the growth and development of digital in out-of-home (OOH) advertising over the past couple of years.

Encounters with healthcare providers (HCPs) requires diligent preparation. Beyond understanding the value of the therapies you're offering, all touchpoints and conversations are of the highest importance - through sharing research, new ideas, and how you can support HCPs, you gain valuable, relevant insights that inform your relationship with HCPs and help them blossom.

Ed Thesiger is promoted to lead the agency through the next phase of growth.